Non-mycobacterial bacteriology research in MIP is diverse and is directed towards drug resistant pathogens (e.g. Pseudomonas aeruginosa, Acinetobacter baumannii, and Burkholderia species) and emerging pathogens or bacteria of biodefense importance (e.g. Burkholderia pseudomallei, Francisella tularensis, and Yersinia pestis). Efforts include studying antibacterial resistance mechanisms, identification of novel drug targets, drug discovery and development, immunotherapy, bacterial physiology, mechanisms of pathogenesis, development of animal models for emerging infectious diseases and vaccine discovery. These studies are facilitated by state-of-the-art BSL2, BSL3 and ABSL3 laboratory facilities. Many of these are located in the Infectious Diseases Research Complex on CSU's Foothills Campus which includes the Rocky Mountain Regional Biocontainment Laboratory, one of only 13 such facilities nationwide.
M. tuberculosis, F. tularensis vaccine discovery and physiology
M. tuberculosis, B. pseudomallei, F. tularensis, and Y. pestis drug discovery and development
P. aeruginosa biofilms
B. pseudomallei and F. tularensis immunotherapy, vaccines and animal models
B. pseudomallei drug discovery and development
Animal models of infectious disease
P. aeruginosa and B. pseudomallei biofilm development and pathogenesis